Spatial Genomics & Transcriptomics Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Spatial Genomics & Transcriptomics Market

Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Translational Research, Drug Discovery), End User, Global Forecast to 2027

FREE BROCHURE FREE SAMPLE REPORT
Report Code: BT 7790 Dec, 2022, by marketsandmarkets.com

The global spatial genomics & transcriptomics market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the government approved R&D investments, growing need for early diagnosis and remedial treatment and developing innovative products. sOn the other hand, high capital investments, and dearth of skilled professionals are some factors limiting the market growth.

Attractive Opportunities in the Spatial Genomics & Transcriptomics Market

Spatial Genomics & Transcriptomics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Global Spatial Genomics & Transcriptomics Market Dynamics

DRIVER: Increasing adoption of spatial genomics & transcriptomics in drug discovery & development

In recent years, spatial genomics and transcriptomics have shifted from strictly research applications to drug discovery & development applications. Genomics and transcriptomics are major tools for accelerating drug discovery & development processes. Spatial techniques are presently in use to enhance the understanding of infectious diseases. Applications of spatial genomics & transcriptomics are expanding with time, targeted towards generating insights into neurodegenerative diseases and cancer. Spatial genomics and transcriptomics is also anticipated to address the one of the current unmet clinical needs in the field of oncology, which is the need for predictive biomarkers of response. These biomarkers assist in developing immunotherapies by offering a greater understanding of the microenvironment of tumor.

CHALLENGES: Dearth of skilled professionals

Lack of knowledge regarding the underlying scientific principles and the right choice of technique may result in several direct and indirect expenses and, thereby, increase the workload and time pressure on researchers and service providers. Thus, there is a need for highly skilled personnel for method development, validation, operation, and troubleshooting activities. Lack of clarity around outcomes of transcriptomic research, coupled with the high equipment cost, has led to the lower adoption of transcriptomic technologies, thereby limiting the spread of technical knowledge related to transcriptomics research.

The Spatial Transcriptomics accounted for the largest share of the technique segments in spatial genomics & transcriptomics market in 2022.

The spatial genomics & transcriptomics market is segmented into technique, product, application, and end user. Based on technique, the segment is categorized into spatial transcriptomics, and spatial genomics analysis. In 2022, the spatial transcriptomics segment accounted for the largest share of the spatial genomics and transcriptomics market. Increasing demand for and high adoption rate of in situ sequencing techniques is expected to drive the growth of the spatial transcriptomics segment during the forecast period.

The Consumables segment dominated the product segment in spatial genomics & transcriptomics market in 2022.

Based on the product, the segment is categorized into consumables, instruments and software. In 2022, the consumables segment dominated the product segment with the highest revenue share. Growing use of consumables for various spatial genomics and transcriptomics applications is estimated to drive the market growth.

In 2022, the translational research segment have generated highest revenue in the application segment for spatial genomics & transcriptomics market.

Based on the application, the global spatial genomics & transcriptomics market is segmented into translational research, and drug discovery & development. In 2022, the translational research have generated highest revenue in the application segment. The large share of the translational research segment can be attributed to the increasing use of spatial genomics and transcriptomics to determine high-throughput data on the organizational structure of cell content from tissue and cell species.

North America was the largest regional market for spatial genomics & transcriptomics in 2022.

Geographically, the spatial genomics & transcriptomics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The spatial genomics & transcriptomics market is dominated by the North America region in 2022 and this dominance is anticipated to continue throughout the forecast period. The large share of the North American regional segment can be attributed to the rising incidence of chronic diseases and technological advancements and the launch of cell therapies to treat different cancers in the spatial genomics and transcriptomics market in this region.

Spatial Genomics & Transcriptomics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Prominent players in the spatial genomics & transcriptomics market include NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Natera, Inc. (US), PerkinElmer, Inc. (US), Seven Bridges Genomics (US), S2 Genomics, Inc. (US), Cantata Bio (US), Vizgen Corporation (US), BioSpyder Technologies Inc. (US), Optical Biosystems Inc. (US), Miltenyi Biotec (Germany), Ultivue Inc. (US), Lunaphore Technologies SA (Switzerland), Rebus Biosystems LLC (US), Resolve Biosciences (Germany), Singular Genomics, Inc. (US), and Veracyte (US).

Want to explore hidden markets that can drive new revenue in Spatial Genomics & Transcriptomics Market?

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Product, Technique, Application, End User and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Companies covered

NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Natera, Inc. (US), PerkinElmer, Inc. (US), Seven Bridges Genomics (US), S2 Genomics, Inc. (US), Cantata Bio (US), Vizgen Corporation (US), BioSpyder Technologies Inc. (US), Optical Biosystems Inc. (US), Miltenyi Biotec (Germany), Ultivue Inc. (US), Lunaphore Technologies SA (Switzerland), Rebus Biosystems LLC (US), Resolve Biosciences (Germany), Singular Genomics, Inc. (US), and Veracyte (US).

This report categorizes the spatial genomics & transcriptomics market into the following segments:

Spatial Genomics & Transcriptomics Market, by Technique
  • Spatial Transcriptomics
  • Immunohistochemistry (IHC)
  • In Situ Hybridization
  • Sequencing Techniques
  • Microscopy based RNA imaging
  • Other Spatial Transcriptomics Techniques
  • Spatial Genomics Analysis
  • Immunohistochemistry (IHC)
  • In Situ Hybridization
  • Sequencing Techniques
  • Microscopy based RNA imaging
  • Other Spatial Transcriptomics Techniques
Spatial Genomics & Transcriptomics Market, by Product
  • Instruments
  • Consumables
  • Software
Spatial Genomics & Transcriptomics Market, by Application
Spatial Genomics & Transcriptomics Market, by End User
  • Academic and Research Institutes
  • Contract Research Organization
  • Pharmaceutical and Biotechnology Companies
Spatial genomics & transcriptomics Market, by Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • India
    • China
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Rest of Middle East and Africa

Recent Developments

  • In 2022, NanoString and Abcam announced an agreement to co-market Abcam antibodies for NanoString’s high-plex spatial multiomics solutions.
  • In 2022, 10x Genomics announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling of genes and proteins at subcellular resolution.
  • In 2022, Illumina and AstraZeneca announced a strategic research collaboration to accelerate drug target discovery by combining their strengths in AI-based genome interpretation and genomic analysis techniques with industry expertise.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 35)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 STUDY SCOPE 
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
    1.6 LIMITATIONS 
    1.7 STAKEHOLDERS 
 
2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                   FIGURE 2 BREAKDOWN OF PRIMARIES: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
          FIGURE 4 SPATIAL GENOMICS MARKET SIZE, 2021 (USD MILLION)
          FIGURE 5 SPATIAL TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027)
          FIGURE 6 SPATIAL GENOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, AND CHALLENGES
    2.3 MARKET DATA ESTIMATION & TRIANGULATION 
           2.3.1 DATA TRIANGULATION
                   FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 INDUSTRY INSIGHTS 
    2.5 RESEARCH ASSUMPTIONS 
 
3 EXECUTIVE SUMMARY (Page No. - 45)
    FIGURE 8 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
    FIGURE 9 SPATIAL TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2021 VS. 2027 (USD MILLION)
    FIGURE 10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION, 2021 VS. 2027
    FIGURE 11 SPATIAL GENOMICS MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
    FIGURE 12 GEOGRAPHICAL SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 49)
    4.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET OVERVIEW 
          FIGURE 13 INCREASING ADOPTION OF SPATIAL GENOMICS & TRANSCRIPTOMICS ANALYSIS IN TRANSLATIONAL RESEARCH TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET SHARE, BY PRODUCT & COUNTRY (2021) 
          FIGURE 14 CONSUMABLES ACCOUNTED FOR LARGEST SHARE IN 2021
    4.3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY END USER (2021) 
          FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
 
5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 16 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 1 SPATIAL GENOMICS MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing adoption of spatial genomics & transcriptomics in drug discovery & development
                    5.2.1.2 Introduction of novel products
                    5.2.1.3 Increasing R&D investments and public-private funding
           5.2.2 RESTRAINTS
                    5.2.2.1 High capital investments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing use of spatial omics for biomarker identification
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of skilled professionals
    5.3 TECHNOLOGY ANALYSIS 
           5.3.1 MULTIPLEXING
           5.3.2 IMAGING-BASED TECHNOLOGICAL ADVANCEMENTS
           5.3.3 DATA ANALYSIS
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
          FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
    5.5 SUPPLY CHAIN ANALYSIS 
          FIGURE 18 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SUPPLY CHAIN ANALYSIS
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 19 SPATIAL TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 20 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
    5.8 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 2 SPATIAL GENOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF BUYERS
           5.8.4 BARGAINING POWER OF SUPPLIERS
           5.8.5 DEGREE OF COMPETITION
    5.9 REGULATORY ANALYSIS 
           5.9.1 FDA APPROVALS
           5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.10 PRICING ANALYSIS 
           TABLE 7 PRICING ANALYSIS OF SPATIAL GENOMICS AND TRANSCRIPTOMICS PRODUCTS
           5.10.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: AVERAGE SELLING PRICE TREND
    5.11 PIPELINE ANALYSIS 
    5.12 KEY CONFERENCES & EVENTS IN 2022–2023 
           5.12.1 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2022-2023)
                     TABLE 8 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2022-2023)
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
           5.13.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS
                     FIGURE 22 KEY BUYING CRITERIA FOR END USERS
 
6 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE (Page No. - 66)
    6.1 INTRODUCTION 
          TABLE 9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    6.2 SPATIAL TRANSCRIPTOMICS 
          TABLE 10 SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 11 SPATIAL TRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 12 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 13 EUROPE: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 15 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 16 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.1 IMMUNOHISTOCHEMISTRY
                    6.2.1.1 Emergence of mIHC/IF to propel growth
                                TABLE 17 IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 18 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 19 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 20 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 21 LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 22 MIDDLE EAST & AFRICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 IN SITU HYBRIDIZATION
                    6.2.2.1 High adoption of MERFISH to drive growth
                                TABLE 23 IN SITU HYBRIDIZATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 24 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 25 EUROPE: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 26 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 27 LATIN AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 28 MIDDLE EAST & AFRICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.3 SEQUENCING
                    TABLE 29 SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 30 NORTH AMERICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 31 EUROPE: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 32 ASIA PACIFIC: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 33 LATIN AMERICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 34 MIDDLE EAST & AFRICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.3.1 Microdissection-based sequencing
                               6.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth
                    6.2.3.2 In situ sequencing
                               6.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth
           6.2.4 OTHER SEQUENCING TECHNOLOGIES
           6.2.5 MICROSCOPY-BASED RNA IMAGING
                    6.2.5.1 Rising use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth
                                TABLE 35 MICROSCOPY-BASED RNA IMAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 36 NORTH AMERICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 37 EUROPE: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 38 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 39 LATIN AMERICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 40 MIDDLE EAST & AFRICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.6 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES
    6.3 SPATIAL GENOMICS ANALYSIS 
          TABLE 41 SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 42 SPATIAL GENOMICS ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 43 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 44 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 45 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 46 LATIN AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 47 MIDDLE EAST & AFRICA: OTHER SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.1 FLUORESCENCE IN SITU HYBRIDIZATION
                    6.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support market growth
                                TABLE 48 FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 49 NORTH AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 50 EUROPE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 51 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 52 LATIN AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 53 MIDDLE EAST & AFRICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.2 SEQUENCING
                    6.3.2.1 Rising adoption of massively parallel sequencing to drive growth
                                TABLE 54 SEQUENCING TECHNIQUES MARKET FOR SPATIAL GENOMICS ANALYSIS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 55 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 56 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 57 ASIA PACIFIC: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 58 LATIN AMERICA: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 59 MIDDLE EAST & AFRICA: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES
                    TABLE 60 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 61 NORTH AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 62 EUROPE: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 63 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 64 LATIN AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 65 MIDDLE EAST & AFRICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT (Page No. - 91)
    7.1 INTRODUCTION 
          TABLE 66 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    7.2 CONSUMABLES 
           7.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE MARKET GROWTH
                    TABLE 67 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 68 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 69 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 70 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 71 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 72 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 INSTRUMENTS 
           7.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET
                    TABLE 73 SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 74 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 75 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 76 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 77 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 78 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 SOFTWARE 
           7.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE
                    TABLE 79 SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 80 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 81 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 82 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 83 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 84 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
 
8 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION (Page No. - 100)
    8.1 INTRODUCTION 
          TABLE 85 SPATIAL GENOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 TRANSLATIONAL RESEARCH 
           8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE SEGMENT GROWTH
                    TABLE 86 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 87 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 88 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 90 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 91 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 DRUG DISCOVERY & DEVELOPMENT 
           8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE MARKET
                    TABLE 92 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 93 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 94 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 95 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 96 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 97 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)
 
9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER (Page No. - 107)
    9.1 INTRODUCTION 
          TABLE 98 SPATIAL TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 ACADEMIC & RESEARCH INSTITUTES 
           9.2.1 INCREASED DEMAND FOR SPATIAL GENOMICS & TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH
                    TABLE 99 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 100 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 101 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 102 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 103 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 104 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 CONTRACT RESEARCH ORGANIZATIONS 
           9.3.1 INCREASING DEPENDENCE ON CONTRACT RESEARCH TO DRIVE MARKET
                    TABLE 105 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 106 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 107 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 108 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 109 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 110 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS & TRANSCRIPTOMICS SYSTEMS
                    TABLE 111 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 112 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 113 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 114 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 115 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 116 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
 
10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION (Page No. - 116)
     10.1 INTRODUCTION 
             FIGURE 23 SPATIAL GENOMICS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
             TABLE 117 SPATIAL TRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 24 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
             TABLE 118 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 119 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 120 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 121 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 122 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 123 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 124 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US to dominate North American market
                                      TABLE 125 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 126 US: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 127 US: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 128 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 129 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 130 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Government initiatives to contribute to market growth
                                      TABLE 131 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 132 CANADA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 133 CANADA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 134 CANADA: SPATIAL GENOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 135 CANADA: SPATIAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 136 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.3 EUROPE 
             TABLE 137 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 138 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 139 EUROPE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 140 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 141 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 142 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 143 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Increasing adoption of spatial genomics and transcriptomics by biopharma & biotech companies to drive market growth
                                      TABLE 144 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 145 GERMANY: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 146 GERMANY: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 147 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 148 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 149 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Rising government support for biotech companies to propel demand for advanced technologies
                                      TABLE 150 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 151 UK: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 152 UK: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 153 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 154 UK: SPATIAL GENOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 155 UK: SPATIAL TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing investments in life sciences R&D infrastructure development to support market growth
                                      TABLE 156 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 157 FRANCE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 158 FRANCE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 159 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 160 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 161 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.4 REST OF EUROPE
                        TABLE 162 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 163 ROE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 164 ROE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 165 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 166 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 167 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC 
             FIGURE 25 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
             TABLE 168 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 169 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 170 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 171 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 172 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 173 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 174 ASIA PACIFIC: SPATIAL GENOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Increasing R&D spending by government and biopharma companies to support market growth
                                      TABLE 175 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 176 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 177 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 178 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 179 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 180 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Rising funding in Japan to boost research applications
                                      TABLE 181 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 182 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 183 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 184 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 185 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 186 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Collaborations between hospitals and diagnostics centers for laboratory services to boost growth
                                      TABLE 187 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 188 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 189 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 190 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 191 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 192 INDIA: SPATIAL GENOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 193 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 194 ROAPAC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 195 ROAPAC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 196 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 197 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 198 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA 
             TABLE 199 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 200 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 201 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 202 LATIN AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 203 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 204 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 205 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Increased adoption of spatial analysis for translational research in Brazil likely to propel market
                                      TABLE 206 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 207 BRAZIL: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 208 BRAZIL: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 209 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 210 BRAZIL: SPATIAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 211 BRAZIL: SPATIAL GENOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Growing attention of investors on opportunities in Mexico to support growth
                                      TABLE 212 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 213 MEXICO: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 214 MEXICO: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 215 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 216 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 217 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                        TABLE 218 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 219 ROLATAM: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 220 ROLATAM: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 221 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 222 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 223 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             TABLE 224 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 225 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 226 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 227 MIDDLE EAST & AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 228 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 229 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 230 MIDDLE EAST & AFRICA: SPATIAL GENOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.6.1 SOUTH AFRICA
                        10.6.1.1 Growing investments in R&D to support market development
                                      TABLE 231 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 232 SOUTH AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 233 SOUTH AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 234 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 235 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 236 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.6.2 REST OF MIDDLE EAST & AFRICA
                        TABLE 237 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 238 ROMEA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 239 ROMEA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 240 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 241 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 242 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 169)
     11.1 INTRODUCTION 
     11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 26 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS) 
             FIGURE 27 REVENUE ANALYSIS FOR TOP SIX COMPANIES, 2018–2021
     11.4 MARKET SHARE ANALYSIS (2021) 
             FIGURE 28 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: MARKET SHARE ANALYSIS OF TOP SIX PLAYERS (2021)
     11.5 COMPANY EVALUATION QUADRANT 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 29 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION QUADRANT (2021)
     11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 30 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
     11.7 COMPETITIVE BENCHMARKING 
             11.7.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF START-UPS/SMES
                        TABLE 243 SPATIAL GENOMICS MARKET: DETAILED LIST OF START-UPS/SMES
                        11.7.1.1 SPATIAL TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
                                      TABLE 244 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES)
     11.8 COMPETITIVE SCENARIO AND TRENDS 
             11.8.1 DEALS
                        TABLE 245 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS
             11.8.2 PRODUCT LAUNCHES
                        TABLE 246 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES
             11.8.3 OTHER DEVELOPMENTS
                        TABLE 247 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS
 
12 COMPANY PROFILES (Page No. - 181)
     12.1 MAJOR PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 NANOSTRING TECHNOLOGIES
                        TABLE 248 NANOSTRING TECHNOLOGIES: BUSINESS OVERVIEW
                        FIGURE 31 NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT (2021)
             12.1.2 10X GENOMICS
                        TABLE 249 10X GENOMICS: BUSINESS OVERVIEW
                        FIGURE 32 10X GENOMICS: COMPANY SNAPSHOT (2021)
             12.1.3 ILLUMINA
                        TABLE 250 ILLUMINA: BUSINESS OVERVIEW
                        FIGURE 33 ILLUMINA: COMPANY SNAPSHOT (2021)
             12.1.4 BIO-RAD LABORATORIES
                        TABLE 251 BIO-RAD: BUSINESS OVERVIEW
                        FIGURE 34 BIO-RAD: COMPANY SNAPSHOT (2021)
             12.1.5 BIO-TECHNE
                        TABLE 252 BIO-TECHNE: BUSINESS OVERVIEW
                        FIGURE 35 BIO-TECHNE: COMPANY SNAPSHOT (2021)
             12.1.6 STANDARD BIOTOOLS
                        TABLE 253 STANDARD BIOTOOLS: BUSINESS OVERVIEW
                        FIGURE 36 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021)
             12.1.7 GENOMIC VISION SA
                        TABLE 254 GENOMIC VISION: BUSINESS OVERVIEW
                        FIGURE 37 GENOMIC VISION: COMPANY SNAPSHOT (2021)
             12.1.8 AKOYA BIOSCIENCES
                        TABLE 255 AKOYA BIOSCIENCES: BUSINESS OVERVIEW
                        FIGURE 38 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021)
             12.1.9 DANAHER CORPORATION
                        TABLE 256 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.10 NATERA
                        TABLE 257 NATERA: BUSINESS OVERVIEW
                        FIGURE 40 NATERA: COMPANY SNAPSHOT (2021)
             12.1.11 PERKINELMER
                        TABLE 258 PERKINELMER: BUSINESS OVERVIEW
                        FIGURE 41 PERKINELMER: COMPANY SNAPSHOT (2021)
             12.1.12 SEVEN BRIDGES GENOMICS
                        TABLE 259 SEVEN BRIDGES GENOMICS: BUSINESS OVERVIEW
             12.1.13 S2 GENOMICS
                        TABLE 260 S2 GENOMICS: BUSINESS OVERVIEW
             12.1.14 CANTATA BIO
                        TABLE 261 CANTATA BIO: BUSINESS OVERVIEW
             12.1.15 VIZGEN CORP
                        TABLE 262 VIZGEN: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 BIOSPYDER TECHNOLOGIES
             12.2.2 OPTICAL BIOSYSTEMS
             12.2.3 MILTENYL BIOTEC
             12.2.4 RARECYTE
             12.2.5 ULTIVUE
             12.2.6 LUNAPHORE TECHNOLOGIES
             12.2.7 REBUS BIOSYSTEMS
             12.2.8 RESOLVE BIOSCIENCES
             12.2.9 SINGULAR GENOMICS
             12.2.10 VERACYTE
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 237)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the spatial genomics & transcriptomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the spatial genomics & transcriptomics market. The secondary sources used for this study include Some of the key secondary sources referred to for this study include publications from government sources World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), International Agency for Research on Cancer (IARC), Research!America, Genome Canada, GenomeWeb, South African Medical Research Council (SAMRC), Wellcome Sanger Institute, Genome Research Limited, Labiotech.eu, R&D World Magazine, India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, Eurostat, Annual Reports, Press Releases, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Spatial Genomics & Transcriptomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the spatial genomics & transcriptomics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the spatial genomics & transcriptomics business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the spatial genomics & transcriptomics market based on product, technique, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities, and trends)
  • To strategically analyse micromarkets with respect to individual growth trends, future prospects, and contributions to the overall spatial genomics & transcriptomics market
  • To analyse opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the spatial genomics & transcriptomics market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles

Regional Analysis

  • Breakdown of RoW into Latin America and Middle East & Africa
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 7790
Published ON
Dec, 2022
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Spatial Genomics & Transcriptomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Want to explore hidden markets that can drive new revenue in Spatial Genomics & Transcriptomics Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback